Whoopi Goldberg and several of her co-hosts on “The View” Thursday found themselves agreeing with Elon Musk’s opinion on weight loss drug Ozempic – a position that clashes with Health and Human Services Secretary-designate Robert F. Kennedy Jr.’s stance on the medication.
Musk, one of President-elect Donald Trump’s closest confidants, has expressed his support for more widespread use of Ozempic to curb America’s obesity epidemic, whereas Kennedy has argued that getting Americans to eat healthier would be more cost-effective.
“Elon’s right on this!” Goldberg declared, echoing co-host Alyssa Farah Griffin after a discussion on the division between the incoming DOGE chief and HHS secretary.
Goldberg, 69, showed off her figure after revealing to the audience that she weighed close to 300 pounds two years ago before she started taking Mounjaro, which like Ozempic is a GLP inhibitor.
GLP inhibitors are a type of drug that helps people regulate their blood glucose and insulin levels for diabetes, but Americans have been using the group of drugs for weight loss.
“This isn’t just about food,” Goldberg argued. “This is sometimes people are born genetically larger.”
The actress and comedian further contended that Kennedy’s focus on diet was “setting folks up for shame.”
“That’s what you’re trying — maybe you don’t know you’re doing it. I’m going to give you the benefit of the doubt. I’m going to say you don’t know, you don’t realize what you do to people when you say stuff like that because it doesn’t work for everybody,” Goldberg said.
Later, Joy Behar chimed in to note that Ozempic’s “side effects are not horrible.”
Musk, the billionaire boss of Tesla, SpaceX and X, has long argued that the benefits of GLP inhibitors outweigh the potential costs.
“Nothing would do more to improve the health, lifespan and quality of life for Americans than making GLP inhibitors super low cost to the public,” Musk wrote on X Wednesday. “Nothing else is even close.”
Meanwhile, Kennedy, in a recent interview with Fox News’ Greg Gutfeld, scoffed at the amount of money it would take to make Ozempic available to everyone who is overweight, claiming it would cost “$3 trillion a year.”
“If we spent one-fifth of that, giving three meals a day to every man, woman and child in our country, we could solve the obesity and diabetes epidemic overnight,” the 70-year-old former environmental attorney said.
